EZAMBRIS

EUIPO EUIPO 2016 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark EZAMBRIS was filed as Word mark on 12/12/2016 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/08/2017. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 016155293
Application date December 12, 2016
Publication date March 1, 2017
Entry date June 8, 2017
Expiration date December 12, 2026

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the prevention, treatment and diagnosis of Alzheimer's, anxiety disorders, atherosclerosis and autoimmune diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and/or treatment of blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, and diabetes; pharmaceutical preparations for the prevention, treatment and diagnosis of dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders and metabolic diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and/or treatment of migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders; pharmaceutical preparations for the prevention, treatment and diagnosis of Parkinson's disease, psychiatric disorders, sleep disorders and urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases; Pharmaceutical preparations

Trademark history

Date Document number Area Entry
April 5, 2019 Change Representative, Published
December 20, 2018 Change Representative, Published

ID: 11016155293